George N Konstantinou
Overview
Explore the profile of George N Konstantinou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
744
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Porpodis K, Zias N, Kostikas K, Tzouvelekis A, Makris M, Konstantinou G, et al.
Clin Transl Allergy
. 2025 Jan;
15(2):e70035.
PMID: 39887925
Background: Data on type 2 (T2)-low severe asthma (SA) frequency is scarce, resulting in an undefined unmet therapeutic need in this patient population. Our objective was to assess the frequency...
2.
Miligkos M, Oh J, Kwon R, Konstantinou G, Kim S, Yon D, et al.
Ann Allergy Asthma Immunol
. 2024 Dec;
PMID: 39674277
In the past 3 decades, the overall prevalence of asthma appears to be plateauing, although large geographic and socioeconomic variation is evident. Overall, asthma prevalence slightly decreased in most age...
3.
Vassilopoulou E, Comotti A, Athanasaki D, Milani G, Agostoni C, Konstantinou G
Pediatr Rep
. 2024 Nov;
16(4):1054-1063.
PMID: 39585044
The prevalence of food allergy is increasing, posing a significant health concern. Assessing health-related quality of life (HRQOL) in individuals with food allergies is crucial, and various questionnaires exist for...
4.
Al-Shaikhly T, Cox A, Nowak-Wegrzyn A, Cianferoni A, Katelaris C, Ebo D, et al.
J Allergy Clin Immunol Pract
. 2024 Nov;
12(12):3242-3249.e1.
PMID: 39488768
Background: Pollen-food allergy syndrome (PFAS) is common among patients with allergic rhinitis. Treatment recommendations for patients with PFAS remain variable. Objective: To develop consensus recommendation statements for managing patients with...
5.
Santos A, Riggioni C, Agache I, Akdis C, Akdis M, Alvarez-Perea A, et al.
Allergy
. 2024 Oct;
80(1):14-36.
PMID: 39473345
This European Academy of Allergy and Clinical Immunology (EAACI) guideline provides recommendations for the management of IgE-mediated food allergy and was developed using the Grading of Recommendations, Assessment, Development and...
6.
Konstantinou G, Podder I
Cureus
. 2024 Jul;
16(5):e61453.
PMID: 38947573
Omalizumab, a humanized anti-IgE monoclonal antibody, is commonly employed in the treatment of antihistamine-refractory chronic spontaneous urticaria (CSU), where it significantly reduces free IgE levels, minimizing histamine release from basophils...
7.
Vassilopoulou E, Comotti A, Douladiris N, Konstantinou G, Zuberbier T, Alberti I, et al.
Allergy
. 2024 May;
79(7):1708-1724.
PMID: 38783644
This systematic review and meta-analysis aimed to consolidate evidence on dietary interventions for atopic eczema/dermatitis (AD) skin symptoms in children without food allergies, following PRISMA 2020 guidelines. Systematic review updates...
8.
Dinas S, Diakou A, Vasiliadis K, Chaintoutis S, Massa E, Konstantinou G, et al.
Pathogens
. 2024 Feb;
13(2).
PMID: 38392887
Consumption of raw and mildly processed seafood, in the context of modern Western world eating trends, is recognized as a major driver for human fish-borne infections. However, these zoonoses and...
9.
Milani G, Alberti I, Abodi M, Lakoumentas J, Konstantinou G, Papadopoulos N, et al.
Allergy
. 2024 Jan;
79(7):1687-1707.
PMID: 38174413
Acute respiratory infections are a major cause of morbidity and mortality in children worldwide. Dietary and nutritional interventions, including minerals and vitamin supplementation, have been explored as potential treatments for...
10.
Schmid-Grendelmeier P, Gooderham M, Hartmann K, Konstantinou G, Fellmann M, Koulias C, et al.
Allergy
. 2023 Nov;
79(1):174-183.
PMID: 37988255
Background: Abrocitinib efficacy by comorbidity status in patients with moderate-to-severe atopic dermatitis (AD) has not been previously assessed. This post hoc analysis evaluated the efficacy and safety of abrocitinib in...